175551-77-6

Basic information

• Product Name: METHYL 2-BROMOMETHYL-4-OXAZOLECARBOXYLATE
• Synonyms: METHYL 2-BROMOMETHYL-4-OXAZOLECARBOXYLATE;2-Bromethyl-oxazole-4-carboxylic acid methyl ester;2-BroMoMethyl-4-oxazolecarboxylic acid Methyl ester;Methyl 2-(bromomethyl)oxazole-4-carboxylate
• CAS NO: 175551-77-6
• Molecular Formula: C₆H₆BrNO₃
• Molecular Weight: 220.02
• Product Categories: pharmacetical
• Mol File: 175551-77-6.mol
• Article Data: 5

Chemical Properties

• Melting Point: 49-51℃
• Boiling Point: 245℃
• Flash Point: 102℃
• Appearance: /
• Density: 1.656
• Vapor Pressure: 0.029mmHg at 25°C
• Refractive Index: 1.53
• Storage Temp.: 2-8°C
• CAS DataBase Reference: METHYL 2-BROMOMETHYL-4-OXAZOLECARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 2-BROMOMETHYL-4-OXAZOLECARBOXYLATE(175551-77-6)
• EPA Substance Registry System: METHYL 2-BROMOMETHYL-4-OXAZOLECARBOXYLATE(175551-77-6)

Safety Data

• Hazardous Substances Data: 175551-77-6(Hazardous Substances Data)

Usage

General Description

Methyl 2-bromomethyl-4-oxazolecarboxylate is a chemical compound with the formula C6H6BrNO3. It is a synthetic organic compound commonly used as an intermediate in the manufacture of pharmaceuticals and agrochemicals. The compound features a bromomethyl substituent at the 2-position and an oxazolecarboxylate ester functional group, making it a versatile building block for the synthesis of more complex molecules. It is important to handle and store this chemical in accordance with safe laboratory practices to prevent any harm to human health or the environment.

InChI:InChI=1/C6H6BrNO3/c1-10-6(9)4-3-11-5(2-7)8-4/h3H,2H2,1H3

Upstream product

• 85806-67-3 2-methyl-oxazole-4-carboxylic acid methyl ester 
• 87027-39-2 t-butyl 2-(bromomethyl)oxazole-4-carboxylate 
• 186581-53-3 diazomethane 

Downstream Products

• 175551-76-5 (12E,17E,19E)-(7R,10R,11R,21S)-21-(tert-Butyl-diphenyl-silanyloxy)-10-isopropyl-11,19-dimethyl-9,26-dioxa-3,15,28-triaza-tricyclo[23.2.1.0^3,7]octacosa-1⁽²⁷⁾,12,17,19,25⁽²⁸⁾-pentaene-2,8,14,23-tetraone 
• 21102-49-8 virginiamycin M2 
• 208465-69-4 (R)-((3R,4R,E)-7-((S,2E,4E)-8-(tert-butyldimethylsilyloxy)-6-(tert-butyldiphenylsilyloxy)-4-methylocta-2,4-dienylamino)-2,4-dimethyl-7-oxohept-5-en-3-yl) 1-(2-(chloromethyl)-oxazole-4-carbonyl)pyrrolidine-2-carboxylate 
• 208465-71-8 (R)-1-(2-Iodomethyl-oxazole-4-carbonyl)-pyrrolidine-2-carboxylic acid (E)-(1R,2R)-4-[(2E,4E)-(S)-6-(tert-butyl-diphenyl-silanyloxy)-8-hydroxy-4-methyl-octa-2,4-dienylcarbamoyl]-1-isopropyl-2-methyl-but-3-enyl ester 
• 208465-70-7 (R)-((3R,4R,E)-7-((S,2E,4E)-6-(tert-butyldiphenylsilyloxy)-8-hydroxy-4-methylocta-2,4-dienylamino)-2,4-dimethyl-7-oxohept-5-en-3-yl) 1-(2-(chloromethyl)oxazole-4-carbonyl)pyrrolidine-2-carboxylate 
• 208465-60-5 (R)-((3R,4R,E)-7-((S,2E,4E)-6-(tert-butyldiphenylsilyloxy)-4-methyl-8-oxoocta-2,4-dienylamino)-2,4-dimethyl-7-oxohept-5-en-3-yl) 1-(2-(iodomethyl)oxazole-4-carbonyl)pyrrolidine-2-carboxylate 
• 221323-69-9 2-[(dicyclohexylamino)-methyl]-oxazole-4-carboxylic acid methyl ester 
• 221323-71-3 2-(4-phenyl-piperazin-1-ylmethyl)-oxazole-4-carboxylic acid methyl ester 
• 208465-67-2 2-iodomethyloxazole-4-carboxylic acid methyl ester 
• 208465-72-9 methyl 2-(chloromethyl)-1,3-oxazole-4-carboxylate 

Relevant articles and documents

PYRIDAZINE DERIVATIVES AS RORc MODULATORS

Compounds of formula I: or pharmaceutical salts thereof, wherein m, A, X, Y, Z, R1, R2, R3, R4 and R5are as defined herein. Also disclosed are methods of making the compounds and using the compounds f

Discovery of further pyrrolidine trans-lactams as inhibitors of human neutrophil elastase (HNE) with potential as development candidates and the crystal structure of HNE complexed with an inhibitor (GW475151)

Described herein is a modern approach to the rapid preparation and evaluation of compounds as potential back-up drug candidates. GW311616A, 1, a derivative of pyrrolidine trans-lactams, has previously been described as a potent, orally active inhibitor of

Total synthesis of (-)-virginiamycin M2 using second-generation vinylogous urethane chemistry

Antibiotics known as the virginiamycins consist of two groups-polyunsaturated macrolactones (type A) and peptidic macrolactones (type B). Mixtures of type A and type B virginiamycins exhibit very high potency against a variety of bacteria. Total syntheses